Featured Research

from universities, journals, and other organizations

Eliminating tumor suppressor C/EBP alpha explains cancer in aging liver

Date:
June 1, 2010
Source:
Baylor College of Medicine
Summary:
Understanding how the tumor suppressor protein C/EBP alpha is eliminated in aging livers gives important clues to the mechanism by which cancer occurs in that organ and could point the way to new therapies and prevention, say researchers. A variant of C/EBP alpha called the S193-ph isoform is such a powerful tumor suppressor protein that it must be eliminated before liver cancer can occur.

Understanding how the tumor suppressor protein C/EBP alpha is eliminated in aging livers gives important clues to the mechanism by which cancer occurs in that organ and could point the way to new therapies and prevention, say Baylor College of Medicine researchers in a report that appears online in the Journal of Clinical Investigation.

A variant of C/EBP alpha called the S193-ph isoform is such a powerful tumor suppressor protein that it must be eliminated before liver cancer can occur, said Dr. Nikolai A. Timchenko, professor in the Huffington Center on Aging and the department of immunology and pathology at BCM.

"Understanding the molecular mechanism behind the development of liver cancer will help develop new ways to prevent the disease," he said.

The process is multi-step. Another protein -- gankyrin, short for gann ankyrin repeat protein (Gann means cancer in Japanese) -- must be elevated first.

"It is a small molecule that is part of the protein degradation system in the cell," he said. "Previously, it has been shown that this protein eliminates the p53 and RB (retinoblastoma) proteins, both tumor suppressor proteins in other cancers. This is a tumor suppressor killer."

To demonstrate how the mechanism works, he and his colleagues compared tissues from young mice expressing a specific variant of C/EBP alpha and tissues from wild type old mice. If part of the liver is removed in these mice, this tumor suppressor prevents generation of new liver tissue -- indicating that it stalls rapid growth. Uncontrolled growth is a hallmark of cancer.

In these special mice, they found that gankyrin plays an important role in making C/EBP alpha a target for degradation within the cell.

"Cancer is increased in many tissues of older people," he said. "The information we have is specific for the liver, but it might also be important for other kinds of cancer. We do not know yet."

Others who took part in this research include Guo-Li Wang, Xiurong Shi, Simon Haefliger, Jingling Jin, Angela Major, Polina Iakova and Milton Finegold, all of BCM.


Story Source:

The above story is based on materials provided by Baylor College of Medicine. Note: Materials may be edited for content and length.


Journal Reference:

  1. Guo-Li Wang, Xiurong Shi, Simon Haefliger, Jingling Jin, Angela Major, Polina Iakova, Milton Finegold, Nikolai A. Timchenko. Elimination of C/EBP-alpha through the ubiquitin-proteasome system promotes the development of liver cancer in mice. Journal of Clinical Investigation, 2010; DOI: 10.1172/JCI41933

Cite This Page:

Baylor College of Medicine. "Eliminating tumor suppressor C/EBP alpha explains cancer in aging liver." ScienceDaily. ScienceDaily, 1 June 2010. <www.sciencedaily.com/releases/2010/06/100601124125.htm>.
Baylor College of Medicine. (2010, June 1). Eliminating tumor suppressor C/EBP alpha explains cancer in aging liver. ScienceDaily. Retrieved July 24, 2014 from www.sciencedaily.com/releases/2010/06/100601124125.htm
Baylor College of Medicine. "Eliminating tumor suppressor C/EBP alpha explains cancer in aging liver." ScienceDaily. www.sciencedaily.com/releases/2010/06/100601124125.htm (accessed July 24, 2014).

Share This




More Health & Medicine News

Thursday, July 24, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Condemned Man's US Execution Takes Nearly Two Hours

Condemned Man's US Execution Takes Nearly Two Hours

AFP (July 24, 2014) America's death penalty debate raged Thursday after it took nearly two hours for Arizona to execute a prisoner who lost a Supreme Court battle challenging the experimental lethal drug cocktail. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com
China's Ageing Millions Look Forward to Bleak Future

China's Ageing Millions Look Forward to Bleak Future

AFP (July 24, 2014) China's elderly population is expanding so quickly that children struggle to look after them, pushing them to do something unexpected in Chinese society- move their parents into a nursing home. Duration: 02:07 Video provided by AFP
Powered by NewsLook.com
Hundreds in Virginia Turn out for a Free Clinic to Manage Health

Hundreds in Virginia Turn out for a Free Clinic to Manage Health

AFP (July 24, 2014) America may be the world’s richest country, but in terms of healthcare, the World Health Organisation ranks it 37th - prompting hundreds in Virginia to turn out for a free clinic run by “Remote Area Medical”. Duration 02:40 Video provided by AFP
Powered by NewsLook.com
Idaho Boy Helps Brother With Disabilities Complete Triathlon

Idaho Boy Helps Brother With Disabilities Complete Triathlon

Newsy (July 23, 2014) An 8-year-old boy helped his younger brother, who has a rare genetic condition that's confined him to a wheelchair, finish a triathlon. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins